166 related articles for article (PubMed ID: 31308691)
1. C-terminal of E1A binding protein 1 enhances the migration of gastric epithelial cells and has a clinicopathologic significance in human gastric carcinoma.
Wang C; Wang M; Xing B; Chi Z; Wang H; Lie C; Dong H
Onco Targets Ther; 2019; 12():5189-5200. PubMed ID: 31308691
[TBL] [Abstract][Full Text] [Related]
2. C-terminal of E1A binding protein 2 promotes the malignancy of osteosarcoma cells via JAK1/Stat3 signaling.
Wang P; Yu B; Wang C; Zhou S
J Cell Commun Signal; 2020 Mar; 14(1):67-76. PubMed ID: 31214864
[TBL] [Abstract][Full Text] [Related]
3. Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.
Birts CN; Harding R; Soosaipillai G; Halder T; Azim-Araghi A; Darley M; Cutress RI; Bateman AC; Blaydes JP
Biol Cell; 2010 Jan; 103(1):1-19. PubMed ID: 20964627
[TBL] [Abstract][Full Text] [Related]
4. C-Terminus of E1A Binding Protein 1 Stimulates Malignant Phenotype in Human Hepatocellular Carcinoma.
Zhu Y; Wu D; Wang M; Li W
Med Sci Monit; 2019 Nov; 25():8660-8670. PubMed ID: 31860631
[TBL] [Abstract][Full Text] [Related]
5. CLDN10 promotes a malignant phenotype of osteosarcoma cells via JAK1/Stat1 signaling.
Zhang X; Wang X; Wang A; Li Q; Zhou M; Li T
J Cell Commun Signal; 2019 Sep; 13(3):395-405. PubMed ID: 30796717
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma.
Sun L; Feng L; Cui J
Diagn Pathol; 2018 Sep; 13(1):72. PubMed ID: 30219077
[TBL] [Abstract][Full Text] [Related]
7. Pre-mRNA processing factor 3 enhances the progression of keratinocyte-derived cutaneous squamous cell carcinoma by regulating the JAK2/STAT3 pathway.
Zuo S; Li X; Bao W; Li S
Sci Rep; 2020 Jun; 10(1):8863. PubMed ID: 32483193
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.
Filograna A; De Tito S; Monte ML; Oliva R; Bruzzese F; Roca MS; Zannetti A; Greco A; Spano D; Ayala I; Liberti A; Petraccone L; Dathan N; Catara G; Schembri L; Colanzi A; Budillon A; Beccari AR; Del Vecchio P; Luini A; Corda D; Valente C
J Exp Clin Cancer Res; 2024 May; 43(1):137. PubMed ID: 38711119
[TBL] [Abstract][Full Text] [Related]
9. Linc01555 promotes proliferation, migration and invasion of gastric carcinoma cells by interacting with Notch signaling pathway.
Zhao X; Zhao Z
J BUON; 2020; 25(2):1007-1012. PubMed ID: 32521899
[TBL] [Abstract][Full Text] [Related]
10. Changes in C-terminal binding protein 2 (CtBP2) corepressor complex induced by E1A and modulation of E1A transcriptional activity by CtBP2.
Zhao LJ; Subramanian T; Chinnadurai G
J Biol Chem; 2006 Dec; 281(48):36613-23. PubMed ID: 17023432
[TBL] [Abstract][Full Text] [Related]
11. CtBP2 Promotes Human Cancer Cell Migration by Transcriptional Activation of Tiam1.
Paliwal S; Ho N; Parker D; Grossman SR
Genes Cancer; 2012 Jul; 3(7-8):481-90. PubMed ID: 23264848
[TBL] [Abstract][Full Text] [Related]
12. NKCC1 promotes proliferation, invasion and migration in human gastric cancer cells via activation of the MAPK-JNK/EMT signaling pathway.
Wang JF; Zhao K; Chen YY; Qiu Y; Zhu JH; Li BP; Wang Z; Chen JQ
J Cancer; 2021; 12(1):253-263. PubMed ID: 33391422
[No Abstract] [Full Text] [Related]
13. Blockage of ETS homologous factor inhibits the proliferation and invasion of gastric cancer cells through the c-Met pathway.
Gu ML; Zhou XX; Ren MT; Shi KD; Yu MS; Jiao WR; Wang YM; Zhong WX; Ji F
World J Gastroenterol; 2020 Dec; 26(47):7497-7512. PubMed ID: 33384550
[TBL] [Abstract][Full Text] [Related]
14. IGF-1-induced MMP-11 expression promotes the proliferation and invasion of gastric cancer cells through the JAK1/STAT3 signaling pathway.
Su C; Wang W; Wang C
Oncol Lett; 2018 May; 15(5):7000-7006. PubMed ID: 29731870
[TBL] [Abstract][Full Text] [Related]
15. MAGI1 inhibits migration and invasion via blocking MAPK/ERK signaling pathway in gastric cancer.
Jia S; Lu J; Qu T; Feng Y; Wang X; Liu C; Ji J
Chin J Cancer Res; 2017 Feb; 29(1):25-35. PubMed ID: 28373751
[TBL] [Abstract][Full Text] [Related]
16. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
[TBL] [Abstract][Full Text] [Related]
17. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
[TBL] [Abstract][Full Text] [Related]
18. CTBP1 strengthens the cisplatin resistance of gastric cancer cells by upregulating RAD51 expression.
Wu Y; Zhao H
Oncol Lett; 2021 Nov; 22(5):810. PubMed ID: 34630717
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of human kallikrein 12 gene expression in gastric cancer.
Zhao EH; Shen ZY; Liu H; Jin X; Cao H
World J Gastroenterol; 2012 Dec; 18(45):6597-604. PubMed ID: 23236234
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-216a inhibits the metastasis of gastric cancer cells by targeting JAK2/STAT3-mediated EMT process.
Tao Y; Yang S; Wu Y; Fang X; Wang Y; Song Y; Han T
Oncotarget; 2017 Oct; 8(51):88870-88881. PubMed ID: 29179483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
